North Carolina Baptist Hospital

Type: Teaching hospital
Where: WINSTON-SALEM, NC
Medicare CCN: 340047
Received: $1,220,581 in 246 records, 2019 ($186,485 general, $1,034,095 research)
Source: CMS Open Payments search ↗

On this site

Federal award recipient: NORTH CAROLINA BAPTIST HOSPITAL Fuzzy (name and state)
Lobbying client: NORTH CAROLINA BAPTIST HOSPITAL Fuzzy (name and state)
Lobbying client: NORTH CAROLINA BAPTIST HOSPITAL Fuzzy (name and state)
Lobbying registrant: NORTH CAROLINA BAPTIST HOSPITAL Fuzzy (name and state)
Nonprofit: NORTH CAROLINA BAPTIST HOSPITAL Fuzzy (name and state)

By year

Program year	Kind	Records	Amount
2019	General payment	91	$186,485
2019	Research payment	155	$1,034,095

By company

Company	Records	Amount	Years
Amgen Inc.	9	$409,790	2019
Merck Sharp & Dohme LLC	87	$288,855	2019
PFIZER INC.	1	$115,566	2019
CSL Behring	25	$109,147	2019
Avanos Medical	6	$64,464	2019
AngioDynamics, Inc.	1	$60,000	2019
Elekta, Inc.	7	$41,374	2019
Ceribell, Inc.	1	$30,800	2019
Skeletal Dynamics Inc	1	$25,000	2019
Elekta Limited	1	$16,000	2019
W. L. Gore & Associates, Inc.	1	$12,000	2019
Stryker Corporation	13	$9,819	2019
Roche Diagnostics Operations, Inc.	6	$9,334	2019
ACELL, INC.	4	$8,454	2019
FUJIFILM SonoSite, Inc.	2	$5,859	2019
Mallinckrodt Enterprises LLC	4	$4,450	2019
KARL STORZ Endoscopy-America	51	$2,790	2019
COLOPLAST CORP	1	$2,000	2019
Phadia US Inc.	1	$1,535	2019
Advanced Respiratory, Inc	2	$1,450	2019
ResMed Corp	1	$700	2019
AMAG Pharmaceuticals, Inc.	1	$700	2019
Zimmer Biomet Holdings, Inc.	1	$144	2019
Boehringer Ingelheim b.v.	14	$118	2019
Masimo Corporation	1	$99	2019
Siemens Medical Solutions USA, Inc.	1	$47	2019
Boehringer Ingelheim Pharmaceuticals, Inc.	1	$35	2019
Aspen Surgical Products, Inc.	1	$27	2019
Linvatec Corporation	1	$18	2019

By nature of payment

Nature	Records	Amount
Research payment	155	$1,034,095
Education	11	$103,112
Consulting Fee	7	$41,374
Grant	4	$27,718
Gift	54	$8,073
Compensation for services other than consulting, including serving as faculty or as a speaker at a v	12	$4,709
Space rental or facility fees (teaching hospital only)	2	$1,450
Charitable Contribution	1	$47

Records

Date	Company	Amount	Nature	Form	Product	Study	Year
2019-12-31	AngioDynamics, Inc.	$60,000	Education	In-kind items and services	Nanoknife Device, Oncology Surgery		2019
2019-12-31	FUJIFILM SonoSite, Inc.	$5,777	Education	In-kind items and services	Edge/Edge II Ultrasound System Device, Medical Device		2019
2019-12-31	Stryker Corporation	$5,110	Gift	In-kind items and services	SURG - SYSTEM 7 Device, SURGICAL		2019
2019-12-31	Roche Diagnostics Operations, Inc.	$384	Research payment	Cash or cash equivalent	CD cobas Reagents Device, Centralized Diagnostics	RD001469	2019
2019-12-31	Zimmer Biomet Holdings, Inc.	$144	Gift	In-kind items and services	Zimmer Biomet Instruments and Implants Device, General		2019
2019-12-31	Roche Diagnostics Operations, Inc.	$143	Research payment	In-kind items and services	CD cobas Reagents Device, Centralized Diagnostics	RD001469	2019
2019-12-31	Masimo Corporation	$99	Education	In-kind items and services	SET and rainbow SET Device, Devices		2019
2019-12-31	Siemens Medical Solutions USA, Inc.	$47	Charitable Contribution	In-kind items and services			2019
2019-12-21	Amgen Inc.	$18,945	Research payment	Cash or cash equivalent		AMG 420_Non-Randomized Open-Label Expansion_Multiple Myeloma_20160370.	2019
2019-12-16	Avanos Medical	$16,512	Research payment	Cash or cash equivalent	COOLIEF* COOLED RADIOFREQUENCY Device, PAIN MANAGEMENT	A Prospective, Multi-center, Randomized, Assessor Blind, Controlled Study Comparing Lateral Branch Cooled Radiofrequency	2019
2019-12-12	CSL Behring	$1,493	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-12-06	Avanos Medical	$1,638	Research payment	Cash or cash equivalent	COOLIEF* COOLED RADIOFREQUENCY Device, PAIN MANAGEMENT	A Prospective, Multi-center, Randomized, Assessor Blind, Controlled Study Comparing Lateral Branch Cooled Radiofrequency	2019
2019-12-05	CSL Behring	$3,318	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-12-05	CSL Behring	$250	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-11-27	Avanos Medical	$19,097	Research payment	Cash or cash equivalent	COOLIEF* COOLED RADIOFREQUENCY Device, PAIN MANAGEMENT	A Prospective, Multi-center, Randomized, Assessor Blind, Controlled Study Comparing Lateral Branch Cooled Radiofrequency	2019
2019-11-27	KARL STORZ Endoscopy-America	$90	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV> Device, UROLOGY		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV> Device, UROLOGY		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV> Device, UROLOGY		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	LIGHT CABLE, 3.5MM X 300CM. LGTH 9.8 FT Device, VIDEOIMAGING		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	CCU, IMAGE 1, HIGH DEF,SDI,ICM,DOM,CE Device, VIDEOIMAGING		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	HOPKINS II TELESCOPE 0, 4 MM Device, ENT		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	CCU, IMAGE 1, HIGH DEF,SDI,ICM,DOM,CE Device, VIDEOIMAGING		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	CCU, IMAGE 1, HIGH DEF,SDI,ICM,DOM,CE Device, VIDEOIMAGING		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV> Device, LAPAROSCOPY		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV> Device, LAPAROSCOPY		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV> Device, UROLOGY		2019
2019-11-26	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	CCU, IMAGE 1, HIGH DEF,SDI,ICM,DOM,CE Device, VIDEOIMAGING		2019
2019-11-22	Merck Sharp & Dohme LLC	$21,793	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-11-21	Amgen Inc.	$1,529	Research payment	In-kind items and services		AMG 420_Non-Randomized Open-Label Expansion_Multiple Myeloma_20160370.	2019
2019-11-21	Merck Sharp & Dohme LLC	$183	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-11-21	Merck Sharp & Dohme LLC	$117	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-11-19	Mallinckrodt Enterprises LLC	$350	Research payment	Cash or cash equivalent		STRATAGRAFT SKIN TISSUE AS AN ALTERNATIVE TO AUTOGRAFTING FULL-THICKNESS COMPLEX SKIN DEFECTS	2019
2019-11-07	CSL Behring	$17,644	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-11-07	CSL Behring	$750	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-11-04	Avanos Medical	$15,410	Research payment	In-kind items and services	COOLIEF* COOLED RADIOFREQUENCY Device, PAIN MANAGEMENT	A Prospective, Multi-center, Randomized, Assessor Blind, Controlled Study Comparing Lateral Branch Cooled Radiofrequency	2019
2019-10-29	Mallinckrodt Enterprises LLC	$3,000	Research payment	Cash or cash equivalent		STRATAGRAFT SKIN TISSUE AS AN ALTERNATIVE TO AUTOGRAFTING FULL-THICKNESS COMPLEX SKIN DEFECTS	2019
2019-10-29	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY		2019
2019-10-29	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	INSTRUMENT PORT SEALS, 10/PKG Device, UROLOGY		2019
2019-10-29	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY		2019
2019-10-25	Elekta, Inc.	$25,000	Consulting Fee	Cash or cash equivalent	Versa HD Device, ELEKTA LINEAR ACCELERATOR		2019
2019-10-21	Skeletal Dynamics Inc	$25,000	Grant	Cash or cash equivalent	Geminus Device, Orthopaedic		2019
2019-10-18	Elekta, Inc.	$259	Consulting Fee	Cash or cash equivalent	Versa HD Device, ELEKTA LINEAR ACCELERATOR		2019
2019-10-18	Merck Sharp & Dohme LLC	$183	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-10-10	CSL Behring	$1,602	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-10-10	CSL Behring	$50	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-10-09	Merck Sharp & Dohme LLC	$5,820	Research payment	Cash or cash equivalent	ZERBAXA Drug, INFECTIOUS DISEASE	A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef	2019
2019-10-09	Stryker Corporation	$1,465	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-10-09	Stryker Corporation	$288	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-10-09	Stryker Corporation	$71	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-10-09	Stryker Corporation	$62	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-10-04	Avanos Medical	$6,105	Research payment	Cash or cash equivalent	COOLIEF* COOLED RADIOFREQUENCY Device, PAIN MANAGEMENT	A Prospective, Multi-center, Randomized, Assessor Blind, Controlled Study Comparing Lateral Branch Cooled Radiofrequency	2019
2019-10-03	CSL Behring	$750	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-10-02	Merck Sharp & Dohme LLC	$9,090	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-10-01	Advanced Respiratory, Inc	$700	Space rental or facility fees (teaching hospital only)	Cash or cash equivalent	The MetaNeb System Device, Airway Clearance Device		2019
2019-09-30	Roche Diagnostics Operations, Inc.	$316	Research payment	In-kind items and services	CD cobas Reagents Device, Centralized Diagnostics	RD001469	2019
2019-09-27	Merck Sharp & Dohme LLC	$776	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-09-27	Merck Sharp & Dohme LLC	$303	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-09-27	Merck Sharp & Dohme LLC	$275	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-09-17	CSL Behring	$7,074	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-09-17	CSL Behring	$50	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-09-13	W. L. Gore & Associates, Inc.	$12,000	Education	Cash or cash equivalent	Vascular Graft Device, Devices		2019
2019-09-10	Amgen Inc.	$9,338	Research payment	In-kind items and services		AMG 404 - FIH and China_20180143	2019
2019-09-10	Merck Sharp & Dohme LLC	$154	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-09-10	Merck Sharp & Dohme LLC	$140	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-09-05	ResMed Corp	$700	Education	Cash or cash equivalent			2019
2019-08-30	Merck Sharp & Dohme LLC	$12,006	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-30	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	INSTRUMENT PORT SEALS, 10/PKG Device, UROLOGY		2019
2019-08-30	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	INSTRUMENT PORT SEALS, 10/PKG Device, UROLOGY		2019
2019-08-30	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	INSTRUMENT PORT SEALS, 10/PKG Device, UROLOGY		2019
2019-08-30	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	INSTRUMENT PORT SEALS, 10/PKG Device, UROLOGY		2019
2019-08-30	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	INSTRUMENT PORT SEALS, 10/PKG Device, UROLOGY		2019
2019-08-30	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	INSTRUMENT PORT SEALS, 10/PKG Device, UROLOGY		2019
2019-08-30	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY		2019
2019-08-27	Merck Sharp & Dohme LLC	$607	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-27	Merck Sharp & Dohme LLC	$183	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-22	Amgen Inc.	$344,604	Research payment	Cash or cash equivalent		AMG 420_Non-Randomized Open-Label Expansion_Multiple Myeloma_20160370.	2019
2019-08-21	Merck Sharp & Dohme LLC	$64,957	Research payment	In-kind items and services	KEYTRUDA Biological, ONCOLOGY	Ph II Study of MK-3475 as Neo-Adjuvant Therapy in TNBC	2019
2019-08-19	FUJIFILM SonoSite, Inc.	$81	Education	In-kind items and services	Edge/Edge II Ultrasound System Device, Medical Device		2019
2019-08-14	Avanos Medical	$5,700	Research payment	Cash or cash equivalent	COOLIEF* COOLED RADIOFREQUENCY Device, PAIN MANAGEMENT	A Prospective, Multi-center, Randomized, Assessor Blind, Controlled Study Comparing Lateral Branch Cooled Radiofrequency	2019
2019-08-13	CSL Behring	$10,933	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-08-13	CSL Behring	$500	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-08-13	Mallinckrodt Enterprises LLC	$350	Research payment	Cash or cash equivalent		STRATAGRAFT SKIN TISSUE IN THE PROMOTION OF AUTOLOGOUS SKIN REGENERATION OF COMPLEX SKIN DEFECTS DUE TO THERMAL BURNS TH	2019
2019-08-08	Merck Sharp & Dohme LLC	$1,107	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$330	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$138	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$124	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$117	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$103	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$94	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$84	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$84	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$78	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$72	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$69	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$62	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$47	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$38	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$36	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$36	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$21	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$17	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$5	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$3	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$1	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-08-08	Merck Sharp & Dohme LLC	$1	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-07-30	Merck Sharp & Dohme LLC	$303	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-07-30	Merck Sharp & Dohme LLC	$45	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-07-26	Merck Sharp & Dohme LLC	$15,475	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-07-25	Merck Sharp & Dohme LLC	$11	Research payment	In-kind items and services	ZERBAXA Drug, INFECTIOUS DISEASE	A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef	2019
2019-07-18	Merck Sharp & Dohme LLC	$607	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-07-18	Merck Sharp & Dohme LLC	$137	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-07-16	Stryker Corporation	$1,105	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-07-16	Stryker Corporation	$164	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-07-16	Stryker Corporation	$54	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-07-16	Stryker Corporation	$25	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-07-15	KARL STORZ Endoscopy-America	$150	Gift	In-kind items and services	26 inch WIDEVIEW HD LED MONITOR Device, VIDEOIMAGING		2019
2019-07-15	KARL STORZ Endoscopy-America	$120	Gift	In-kind items and services	CCU, IMAGE 1, HIGH DEF,SDI,ICM,DOM,CE Device, VIDEOIMAGING		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	NEEDLE HOLDER, 'KOH', MACRO Device, LAPAROSCOPY		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	LIGHT CABLE, 3.5MM X 300CM. LGTH 9.8 FT Device, VIDEOIMAGING		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	CLEARVISION II TUBING SET Device, ENT		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	LIGHT CABLE, 3.5MM X 300CM. LGTH 9.8 FT Device, VIDEOIMAGING		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	INSERT,'BABCOCK',CLAMP,DBL Device, LAPAROSCOPY		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE, HOPKINS, STRAIGHT FORWARD Device, ENT		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	FLEXIBLE CYSTOSCOPE, CHNL:7FR, 15FRX37CM Device, UROLOGY		2019
2019-07-15	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY		2019
2019-07-11	CSL Behring	$343	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-07-10	Merck Sharp & Dohme LLC	$175	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-07-10	Merck Sharp & Dohme LLC	$92	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-07-10	Merck Sharp & Dohme LLC	$0	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-06-30	Roche Diagnostics Operations, Inc.	$43	Research payment	In-kind items and services	CD cobas Reagents Device, Centralized Diagnostics	RD001469	2019
2019-06-26	Merck Sharp & Dohme LLC	$11,495	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-06-25	Merck Sharp & Dohme LLC	$78	Research payment	In-kind items and services	ZERBAXA Drug, INFECTIOUS DISEASE	A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef	2019
2019-06-24	Linvatec Corporation	$18	Grant	In-kind items and services	LINVATEC ARTHROSCOPY Device, ORTHOPEDIC SURGERY		2019
2019-06-23	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY		2019
2019-06-23	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY		2019
2019-06-20	Aspen Surgical Products, Inc.	$27	Gift	Cash or cash equivalent			2019
2019-06-19	PFIZER INC.	$115,566	Research payment	In-kind items and services	BESPONSA Biological, ONCOLOGY	A PHASE 4 OPENLABEL RANDOMIZED STUDY OF TWO INOTUZUMAB OZOGAMICIN DOSE LEVELS IN ADULT PATIENTS WITH RELAPSED OR REFRACT	2019
2019-06-17	Merck Sharp & Dohme LLC	$607	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-06-17	Merck Sharp & Dohme LLC	$91	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-06-11	CSL Behring	$5,618	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-06-11	CSL Behring	$400	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-06-05	Merck Sharp & Dohme LLC	$350	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-31	Merck Sharp & Dohme LLC	$13,923	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-29	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY		2019
2019-05-28	Amgen Inc.	$2,122	Research payment	In-kind items and services		AMG 404 - FIH and China_20180143	2019
2019-05-24	Merck Sharp & Dohme LLC	$949	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-24	Merck Sharp & Dohme LLC	$151	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-17	Merck Sharp & Dohme LLC	$607	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-17	Merck Sharp & Dohme LLC	$91	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-13	ACELL, INC.	$2,731	Education	Cash or cash equivalent			2019
2019-05-13	ACELL, INC.	$2,115	Education	Cash or cash equivalent			2019
2019-05-09	CSL Behring	$11,810	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-05-09	Phadia US Inc.	$1,535	Research payment	In-kind items and services	EliA Device, Autoimmune	Family Member Screening for Celiac Disease	2019
2019-05-09	CSL Behring	$500	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-05-08	Merck Sharp & Dohme LLC	$157	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-08	Merck Sharp & Dohme LLC	$140	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-08	Merck Sharp & Dohme LLC	$31	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-08	Boehringer Ingelheim b.v.	$10	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$10	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$10	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$10	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$10	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$10	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$10	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$10	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Merck Sharp & Dohme LLC	$8	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-08	Boehringer Ingelheim b.v.	$6	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$6	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$6	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$6	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$6	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Boehringer Ingelheim b.v.	$6	Research payment	In-kind items and services		Bleeding in paediatric patients	2019
2019-05-08	Merck Sharp & Dohme LLC	$4	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-08	Merck Sharp & Dohme LLC	$0	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-05-03	Elekta, Inc.	$5,000	Consulting Fee	Cash or cash equivalent	Versa HD Device, ELEKTA LINEAR ACCELERATOR		2019
2019-05-03	Elekta, Inc.	$2,500	Consulting Fee	Cash or cash equivalent	Versa HD Device, ELEKTA LINEAR ACCELERATOR		2019
2019-05-03	Elekta, Inc.	$2,500	Consulting Fee	Cash or cash equivalent	Versa HD Device, ELEKTA LINEAR ACCELERATOR		2019
2019-05-01	Merck Sharp & Dohme LLC	$12,918	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-04-26	Elekta, Inc.	$5,000	Consulting Fee	Cash or cash equivalent	Versa HD Device, ELEKTA LINEAR ACCELERATOR		2019
2019-04-26	Elekta, Inc.	$1,115	Consulting Fee	Cash or cash equivalent	Versa HD Device, ELEKTA LINEAR ACCELERATOR		2019
2019-04-26	Merck Sharp & Dohme LLC	$750	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-04-26	Merck Sharp & Dohme LLC	$607	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-04-26	Merck Sharp & Dohme LLC	$137	Research payment	In-kind items and services	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019
2019-04-25	Amgen Inc.	$8,430	Research payment	In-kind items and services		AMG 420_Non-Randomized Open-Label Expansion_Multiple Myeloma_20160370.	2019
2019-04-19	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY		2019
2019-04-18	KARL STORZ Endoscopy-America	$30	Gift	In-kind items and services	CHOLEDOCHO-FIBERSCOPE, 7.5 CHARR. Device, LAPAROSCOPY		2019
2019-04-16	CSL Behring	$15,588	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-04-16	Mallinckrodt Enterprises LLC	$750	Research payment	Cash or cash equivalent		STRATAGRAFT SKIN TISSUE AS AN ALTERNATIVE TO AUTOGRAFTING FULL-THICKNESS COMPLEX SKIN DEFECTS	2019
2019-04-16	CSL Behring	$400	Research payment	Cash or cash equivalent		Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II	2019
2019-04-12	Stryker Corporation	$1,203	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-04-12	Stryker Corporation	$170	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-04-12	Stryker Corporation	$54	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-04-12	Stryker Corporation	$41	Compensation for services other than consulting, including serving as faculty or as a speaker at a v	Cash or cash equivalent	REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES		2019
2019-04-10	Merck Sharp & Dohme LLC	$7,521	Research payment	Cash or cash equivalent	PREVYMIS Drug, INFECTIOUS DISEASE	A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Leterm	2019

The latest 200 records of 246.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.